Bone Biologics Statistics

Total Valuation

Bone Biologics has a market cap or net worth of $3.76 million. The enterprise value is $1.02 million.

Market Cap	3.76M
Enterprise Value	1.02M

Important Dates

The next estimated earnings date is Friday, August 22, 2025, after market close.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Bone Biologics has 1.61 million shares outstanding. The number of shares has increased by 421.86% in one year.

Current Share Class	1.61M
Shares Outstanding	1.61M
Shares Change (YoY)	+421.86%
Shares Change (QoQ)	+28.35%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	0.12%
Float	1.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.44
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.59

Current Ratio	12.59
Quick Ratio	10.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -129.48% and return on invested capital (ROIC) is -82.64%.

Return on Equity (ROE)	-129.48%
Return on Assets (ROA)	-77.73%
Return on Invested Capital (ROIC)	-82.64%
Return on Capital Employed (ROCE)	-149.58%
Revenue Per Employee	n/a
Profits Per Employee	-$3.74M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.87% in the last 52 weeks. The beta is 1.19, so Bone Biologics's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	-75.87%
50-Day Moving Average	3.68
200-Day Moving Average	5.35
Relative Strength Index (RSI)	29.02
Average Volume (20 Days)	55,600

Short Selling Information

The latest short interest is 33,038, so 2.06% of the outstanding shares have been sold short.

Short Interest	33,038
Short Previous Month	46,240
Short % of Shares Out	2.06%
Short % of Float	2.28%
Short Ratio (days to cover)	0.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.35M
Pretax Income	-5.12M
Net Income	-7.48M
EBITDA	n/a
EBIT	-4.35M
Earnings Per Share (EPS)	-$20.88

Full Income Statement

Balance Sheet

The company has $2.75 million in cash and n/a in debt, giving a net cash position of $2.75 million or $1.71 per share.

Cash & Cash Equivalents	2.75M
Total Debt	n/a
Net Cash	2.75M
Net Cash Per Share	$1.71
Equity (Book Value)	2.91M
Book Value Per Share	5.34
Working Capital	2.91M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.75M
Capital Expenditures	n/a
Free Cash Flow	-3.75M
FCF Per Share	-$2.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bone Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-421.86%
Shareholder Yield	-421.86%
Earnings Yield	-198.60%
FCF Yield	-99.56%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 10, 2025. It was a reverse split with a ratio of 1:6.

Last Split Date	Jun 10, 2025
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1